Found: 20
Select item for more details and to access through your institution.
Concomitant inhibition of PI3K/mTOR signaling pathways boosts antiproliferative effects of lanreotide in bronchopulmonary neuroendocrine tumor cells.
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1308686
- By:
- Publication type:
- Article
Dysregulated autoantibodies targeting vaso- and immunoregulatory receptors in Post COVID Syndrome correlate with symptom severity.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.981532
- By:
- Publication type:
- Article
Immunoadsorption to remove ß2 adrenergic receptor antibodies in Chronic Fatigue Syndrome CFS/ME.
- Published in:
- PLoS ONE, 2018, v. 13, n. 3, p. 1, doi. 10.1371/journal.pone.0193672
- By:
- Publication type:
- Article
Influenza Vaccination in Patients with Common Variable Immunodeficiency (CVID).
- Published in:
- Current Allergy & Asthma Reports, 2017, v. 17, n. 11, p. 1, doi. 10.1007/s11882-017-0749-3
- By:
- Publication type:
- Article
A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-32507-6
- By:
- Publication type:
- Article
A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-32507-6
- By:
- Publication type:
- Article
Author Correction: A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Hand grip strength and fatigability: correlation with clinical parameters and diagnostic suitability in ME/CFS.
- Published in:
- 2021
- By:
- Publication type:
- journal article
The selective PI3Kα inhibitor BYL719 as a novel therapeutic option for neuroendocrine tumors: Results from multiple cell line models.
- Published in:
- PLoS ONE, 2017, v. 12, n. 8, p. 1, doi. 10.1371/journal.pone.0182852
- By:
- Publication type:
- Article
The German Multicenter Registry for ME/CFS (MECFS-R).
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 11, p. 3168, doi. 10.3390/jcm13113168
- By:
- Publication type:
- Article
Impaired Hand Grip Strength Correlates with Greater Disability and Symptom Severity in Post-COVID Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 7, p. 2153, doi. 10.3390/jcm13072153
- By:
- Publication type:
- Article
Observational Study of Repeat Immunoadsorption (RIA) in Post-COVID ME/CFS Patients with Elevated ß2-Adrenergic Receptor Autoantibodies—An Interim Report.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 19, p. 6428, doi. 10.3390/jcm12196428
- By:
- Publication type:
- Article
Autoantibodies to Vasoregulative G-Protein-Coupled Receptors Correlate with Symptom Severity, Autonomic Dysfunction and Disability in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 16, p. 3675, doi. 10.3390/jcm10163675
- By:
- Publication type:
- Article
Tolerability and Efficacy of s.c. IgG Self-Treatment in ME/CFS Patients with IgG/IgG Subclass Deficiency: A Proof-of-Concept Study.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 11, p. 2420, doi. 10.3390/jcm10112420
- By:
- Publication type:
- Article
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Efficacy of Repeat Immunoadsorption.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 8, p. 2443, doi. 10.3390/jcm9082443
- By:
- Publication type:
- Article
Mechanisms of Targeting the MDM2-p53-FOXM1 Axis in Well-Differentiated Intestinal Neuroendocrine Tumors.
- Published in:
- Neuroendocrinology, 2018, v. 107, n. 1, p. 1, doi. 10.1159/000481506
- By:
- Publication type:
- Article
Inhibition of mTOR's Catalytic Site by PKI-587 Is a Promising Therapeutic Option for Gastroenteropancreatic Neuroendocrine Tumor Disease.
- Published in:
- Neuroendocrinology, 2017, v. 105, n. 1, p. 90, doi. 10.1159/000448843
- By:
- Publication type:
- Article
Endothelial dysfunction and altered endothelial biomarkers in patients with post-COVID-19 syndrome and chronic fatigue syndrome (ME/CFS).
- Published in:
- 2022
- By:
- Publication type:
- journal article
Delineating the Association Between Soluble CD26 and Autoantibodies Against G-Protein Coupled Receptors, Immunological and Cardiovascular Parameters Identifies Distinct Patterns in Post-Infectious vs. Non-Infection-Triggered Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
- Published in:
- Frontiers in Immunology, 2021, v. 11, p. N.PAG, doi. 10.3389/fimmu.2021.644548
- By:
- Publication type:
- Article
The European ME/CFS Biomarker Landscape project: an initiative of the European network EUROMENE.
- Published in:
- 2017
- By:
- Publication type:
- journal article